Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hertzel C. Gerstein(McMaster University), Anselmo P. Bordonava, Fernando Laņas(Universidad de La Frontera), William C. Cushman(University of Tennessee Health Science Center), Rafael Díaz(Estudios Clínicos Latinoamérica), Jonathan E. Shaw(St Mary's Hospital), Patricio López‐Jaramillo(Universidad De Santander), Edward Franek(Mossakowski Medical Research Institute, Polish Academy of Sciences), Wayne Huey‐Herng Sheu(National Yang Ming Chiao Tung University), Peter Raubenheimer(University of Cape Town), Mátyás Keltai, Nana Pogosova(National Medical Research Center of Cardiology), Theodora Temelkova‐Kurktschiev, Rao Ps(Fortune Institute of International Business), Fady T. Botros(Eli Lilly (United States)), M Hanefeld(Technische Universität Dresden), Stephanie Hall(Population Health Research Institute), Mark Lakshmanan(Eli Lilly (United States)), Jan Basile(Medical University of South Carolina), Charles Atisso(Eli Lilly (United States)), Denis Xavier(McMaster University), Ines Bartolacci, María Antonietta Barbieri(University of Messina), Raúl Barcudi, Leanne Dyal(Population Health Research Institute), Nicolae Hâncu(Iuliu Hațieganu University of Medicine and Pharmacy), Álvaro Avezum(Sociedade de Nefrologia do Estado de São Paulo), Jeffrey L. Probstfield(National Heart Lung and Blood Institute), Lawrence A. Leiter(St. Michael's Hospital), Prem Pais(St.John's Medical College Hospital), Lars Rydén(Karolinska Institutet), Valdis Pīrāgs(University of Latvia), Ignacio Conget(Universitat de Barcelona), Matthew C. Riddle(Oregon Health & Science University), Andrea Alebuena, Paula Anadon, Maria Arzadun, Gabriel Bolobanich, G.C. Wong(Population Health Research Institute), Gilles R. Dagenais(Institut universitaire de cardiologie et de pneumologie de Québec), Shaun Holt(Victoria University of Wellington), Namsik Chung(Yonsei University), Petr Janský, Eduardo Amoroso, Elizabeth Andreu, Guillermo Aristimuño, Sandra Almagro, Ernesto Muñoz(Universidad de Guadalajara), Mercedes Abella, Helen M. Colhoun(Edinburgh Cancer Research)
Cited by 640
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k